Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
about
Dancing cheek to cheek: Cryptococcus neoformans and phagocytesInvolvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivoCryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural networkMechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan.Cryptococcus neoformans induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta in human microglia: role of specific antibody and soluble capsular polysaccharide.Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformansImmunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microgliaBinding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophagesEffects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune responseIn vivo role of dendritic cells in a murine model of pulmonary cryptococcosisCellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 geneCryptococcal polysaccharides bind to CD18 on human neutrophils.Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.Human neutrophil chemotaxis is modulated by capsule and O antigen from an extraintestinal pathogenic Escherichia coli strain.The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrumPhenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents.The capsule of the fungal pathogen Cryptococcus neoformans.Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils.Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells.Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibodyCellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.What makes Cryptococcus neoformans a pathogen?Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines.Regulated release of cryptococcal polysaccharide drives virulence and suppresses immune infiltration into the central nervous system.The Interface between Fungal Biofilms and Innate Immunity.Masking the Pathogen: Evolutionary Strategies of Fungi and Their Bacterial Counterparts.Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain.Innate Immunity against Cryptococcus, from Recognition to Elimination.
P2860
Q26798926-2445E3C1-1FCB-400B-8D58-433705E8DA4DQ28512482-C1E5165D-2078-421C-9F21-00502BA38886Q33991281-9BB2BFC7-40C1-4B04-9885-19FA3883CDAFQ33999974-5F8CA255-AA3A-407E-843A-CB83F2BA32B5Q34006498-4CE6B81D-26BD-4326-B943-F1A27E7DB7CCQ34007117-D89466C3-E13E-41AF-9C63-E2F6E4D96065Q34118259-2FC8635C-06F7-4826-A2B4-01D48ADC62D6Q34121516-4C5B3D76-F8BF-456E-936D-E1E280C555C5Q34130404-39C2E545-AC91-4462-9523-8CA83DB34091Q34301177-5E0A9C94-7323-47A4-BE86-25F5B313C562Q34530189-FC0DAACB-CE31-422A-87B0-E1DE301B5791Q34721052-26FDC662-1621-4FE1-A497-93397B92AD9BQ35531947-CD687FFE-322D-4A97-91B4-EB360C4FD2F1Q35543970-107FE1FA-4291-40D5-9ABD-AAACD4E0B089Q35546019-08D73DA0-E4A0-4E94-BAFF-27C487CF69FCQ35567072-80AFF2BC-1846-4AEB-A66B-D8DDC46BCE31Q35567548-B5655B68-0100-4997-B349-0172BCB2A599Q36375986-DD8A5484-6C85-4936-AA79-975C5E46DCF3Q36399747-EB53541A-0AFD-45F9-AF80-617C4A2141CFQ36758698-B5B55929-349B-4BB2-BDC8-B455E839A316Q37337879-81B9D559-4F09-4558-A35F-A6AB1A4C4C30Q37351685-312BB040-D576-4675-AB59-FF8661C4E413Q39536867-B130BD72-0CDF-4A2D-9171-541EF893C4BAQ39656137-F76115B7-3C02-4AB9-8117-6ADED7666910Q39822906-F8B1821C-994C-4470-94E7-A685731E3E2FQ39829782-D276DE6F-DCB0-454A-BBCF-6E878ACC1B00Q41695186-0BFF795E-E3EA-4E7A-BC1E-AFFAF779281EQ42254115-E83443D2-939B-4C48-B34E-4167560147BDQ47370987-2B3F6321-0BAE-4CEF-9535-DD33CB579779Q49203638-BA2E8852-634B-457D-9CE4-6A2A3A8AFEC7Q49410181-D44D429B-29F6-46C0-B1E1-66FD7ABB7C11Q52580472-EA36AA49-6D96-42A3-AA4E-D641A2EB46DCQ55421879-31B6D509-9E1C-4545-AB34-8CCA78255679
P2860
Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Intravascular cryptococcal cul ...... ors of leukocyte accumulation.
@ast
Intravascular cryptococcal cul ...... ors of leukocyte accumulation.
@en
type
label
Intravascular cryptococcal cul ...... ors of leukocyte accumulation.
@ast
Intravascular cryptococcal cul ...... ors of leukocyte accumulation.
@en
prefLabel
Intravascular cryptococcal cul ...... ors of leukocyte accumulation.
@ast
Intravascular cryptococcal cul ...... ors of leukocyte accumulation.
@en
P2860
P1476
Intravascular cryptococcal cul ...... tors of leukocyte accumulation
@en
P2093
P2860
P304
P407
P577
1995-03-01T00:00:00Z